EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)VergleichsstudieRandomisierte kontrollierte StudieOpen Access · CC BY-NC 3.0

Comparative Pharmacokinetics and Bioequivalence Evaluation of Two Formulations of Pramipexole Dihydrochloride Extended-Release Tablets in Healthy Chinese Subjects Under Fasted and Fed States: A Randomized, Open-Label, Single-Dose, Two-Period Crossover Clinical Trial

Ling Yang iD, Liangliang Zhang, Zhu Luo

Drug Design, Development and Therapy · 2023

DOI: 10.2147/dddt.s421449 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift Drug Design, Development and Therapy, 2023. Verfasst von Ling Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, West China Hospital, Sichuan University, Chengdu, People's Republic of China. Hauptthemen laut MEDLINE: East Asian People, Pramipexole, Therapeutic Equivalency, Dopamine Agonists. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

East Asian PeoplePramipexoleTherapeutic EquivalencyDopamine AgonistsHumansFastingParkinson DiseaseCross-Over StudiesDelayed-Action PreparationsHealthy VolunteersEating

Stichwörter der Autor:innen

Parkinson’s diseasebioequivalencepharmacokineticspramipexole dihydrochloride extended-release tabletsafety

Substanzen

PramipexoleDelayed-Action PreparationsDopamine Agonists

Autor:innen und Institutionen

  • Department of Neurology, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
  • Clinical Trial Center, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
  • Department of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, People's Republic of China.

ORCID-Profile: Ling Yang

Zitieren

APA

Yang, L., Zhang, L., & Luo, Z. (2023). Comparative Pharmacokinetics and Bioequivalence Evaluation of Two Formulations of Pramipexole Dihydrochloride Extended-Release Tablets in Healthy Chinese Subjects Under Fasted and Fed States: A Randomized, Open-Label, Single-Dose, Two-Period Crossover Clinical Trial. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s421449

Vancouver

Yang L, Zhang L, Luo Z. Comparative Pharmacokinetics and Bioequivalence Evaluation of Two Formulations of Pramipexole Dihydrochloride Extended-Release Tablets in Healthy Chinese Subjects Under Fasted and Fed States: A Randomized, Open-Label, Single-Dose, Two-Period Crossover Clinical Trial. Drug Design, Development and Therapy. 2023. doi:10.2147/dddt.s421449

BibTeX
@article{Yang2023,
  author = {Yang, Ling and Zhang, Liangliang and Luo, Zhu},
  title = {Comparative Pharmacokinetics and Bioequivalence Evaluation of Two Formulations of Pramipexole Dihydrochloride Extended-Release Tablets in Healthy Chinese Subjects Under Fasted and Fed States: A Randomized, Open-Label, Single-Dose, Two-Period Crossover Clinical Trial},
  journal = {Drug Design, Development and Therapy},
  year = {2023},
  doi = {10.2147/dddt.s421449}
}
Kostenlos starten →